Patient Guide: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 42 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06267001
Status: ACTIVE_NOT_RECRUITING
Condition: Non-small Cell Lung Cancer (NSCLC)
Phase: PHASE3

Where You Can Participate

This study is available at 42 locations across the country.

Top locations include:
  • • Ciudad Autonoma Buenos Aires,
  • • Birtinya, Queensland
  • • Clayton, Victoria
  • • And 39 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy - Join Clinical Trial NCTNCT06267001

How to Join This Clinical Trial - NCTNCT06267001

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-small Cell Lung Cancer (NSCLC). Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-small Cell Lung Cancer (NSCLC). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-small Cell Lung Cancer (NSCLC)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06267001 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 42 locations. Find a study site near you:

Clinical Research Site

Ciudad Autonoma Buenos Aires, C1426AGE - Argentina

Status: Contact for availability

Clinical Research Site

Birtinya, Queensland 4575 - Australia

Status: Contact for availability

Clinical Research Site

Clayton, Victoria 3168 - Australia

Status: Contact for availability

Clinical Research Site

Salvador, Bahia, Bahia 40170-380 - Brazil

Status: Contact for availability

Clinical Research Site

Fortaleza, Ceará 60336-232 - Brazil

Status: Contact for availability

Clinical Research Site

Passo Fundo, Rio Grande Do Sul 99010-260 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande Do Sul 91350-200 - Brazil

Status: Contact for availability

Clinical Research Site

Barretos, São Paulo 14784-400 - Brazil

Status: Contact for availability

Clinical Research Site

Sao Paulo, São Paulo 01509-010 - Brazil

Status: Contact for availability

Clinical Research Site

Changzhou, 213003 - China

Status: Contact for availability

And 32 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-small Cell Lung Cancer (NSCLC):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships